基于机器学习的临床数据预测肺癌存活率:一篇综述
Fatimah Abdulazim Altuhaifa1, Khin Than Win2, Guoxin Su2
1School of Computing and Information Technology, University of Wollongong, NSW, 2500, Australia; Saudi Arabia Ministry of Higher Education, Riyadh, Saudi Arabia.
Computers in biology and medicine
|August 25, 2023
概括
机器学习帮助使用临床数据预测肺癌存活率. 然而,许多研究忽视了关键数据的预处理,可能引入偏见并限制准确性.
科学领域:
- 瘤学和医疗信息学
- 人工智能在医疗保健中的应用
背景情况:
- 机器学习 (ML) 越来越多地用于预测患者生存时间.
- 使用临床数据预测肺癌存活率是研究的一个关键领域.
研究的目的:
- 系统地审查使用ML和数据挖掘来预测肺癌存活率的研究.
- 确定在这个领域使用的常见ML模型,数据源和预处理技术.
主要方法:
- 系统的文献综述 关于MEDLINE,Scopus和谷歌学者 (2000-2023) 的文章.
- 包括的研究使用了ML来预测肺癌存活率,使用临床数据.
- 使用预测模型预测偏差风险评估工具评估偏差风险.
主要成果:
- 审查了30项研究;13项使用了监测,流行病学和最终结果 (SEER) 数据.
- 随机森林是最常见的ML模型 (56.6%).
- 大多数研究 (60%) 没有充分解决缺失的数据,规范化或缩放,风险偏差.
结论:
- 自2012年以来,ML用于肺癌存活率预测的使用量显著增长.
- 缺乏数据的不一致处理和大多数研究中缺乏标准化的预处理可能会引入偏见.
- 需要进一步的研究来开发全面的模型,以应对这些数据挑战,以提高准确性.
相关概念视频
Cancer Survival Analysis
383
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
383
Statistical Methods for Analyzing Epidemiological Data
408
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
408
Kaplan-Meier Approach
179
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
179


